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Otopetrin 1 Protects Mice From
Obesity-Associated Metabolic
Dysfunction Through
Attenuating Adipose Tissue
Inflammation
Chronic low-grade inflammation is emerging as
a pathogenic link between obesity and metabolic
disease. Persistent immune activation in white
adipose tissue (WAT) impairs insulin sensitivity and
systemic metabolism, in part, through the actions of
proinflammatory cytokines. Whether obesity
engages an adaptive mechanism to counteract
chronic inflammation in adipose tissues has not
been elucidated. Here we identified otopetrin 1
(Otop1) as a component of a counterinflammatory
pathway that is induced in WAT during obesity.
Otop1 expression is markedly increased in obese
mouse WAT and is stimulated by tumor necrosis
factor-a in cultured adipocytes. Otop1 mutant mice
respond to high-fat diet with pronounced insulin
resistance and hepatic steatosis, accompanied by
augmented adipose tissue inflammation. Otop1
attenuates interferon-g (IFN-g) signaling in
adipocytes through selective downregulation of the
transcription factor STAT1. Using a tagged vector,
we found that Otop1 physically interacts with
endogenous STAT1. Thus, Otop1 defines a unique
target of cytokine signaling that attenuates
obesity-induced adipose tissue inflammation and
plays an adaptive role in maintaining metabolic
homeostasis in obesity.
Diabetes 2014;63:1340–1352 | DOI: 10.2337/db13-1139
Obesity poses significant risk to patient health owing to
its associated metabolic disorders. White adipose tissue
(WAT) stores the bulk of body fat and also plays an
important role in endocrine metabolic signaling (1,2),
whereas brown adipose tissue (BAT) defends against cold
and obesity through uncoupled mitochondrial respiration
(3,4). Obesity is associated with chronic low-grade in-
flammation in adipose tissues (5–9). The pathogenic role
of the persistent activation of inflammatory signaling in
metabolic disease has been demonstrated in numerous
mouse models. An emerging view suggests that attenu-
ating the proinflammatory response may provide signif-
icant metabolic benefits in obesity. While therapeutic
development targeting inflammation remains in its early
stage in humans, several candidates have shown promise,
including salsalate, a prodrug of salicylate (10), and in-
terleukin (IL)-1 receptor antagonists (11). In addition,
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the beneficial effects of peroxisome proliferator–activated
receptor (PPAR)-g agonists have, at least in part, been
attributed to their anti-inflammatory activities (12,13).
The molecular and cellular events that lead to the
engagement and sustained activation of the innate im-
mune system in obesity are complex and remain to be
unraveled. In adipose tissues, obesity-induced in-
flammation is associated with a robust shift of adipose
tissue macrophages from alternatively activated (M2) to
classically activated (M1) subtypes (14,15). This shift
toward proinflammatory macrophage polarization coin-
cides with the development of insulin resistance and has
been proposed as an early event underlying metabolic
dysregulation (16). A parallel shift from anti-in-
flammatory regulatory T cells to CD4+ helper and CD8+
cytotoxic T cells also occurs in WAT during obesity
(17–19). The latter produces proinflammatory cytokines
such as tumor necrosis factor-a (TNF-a), a prototypical
cytokine associated with obesity (20), and interferon-g
(IFN-g), which contribute to chronic inflammation in
adipose tissues. Several pathways downstream of cyto-
kine receptors have been shown to play a role in obesity-
induced inflammation and its metabolic consequences,
including inhibitor of nuclear factor kB kinase-b (IKK-b),
nuclear factor-kB (NFkB), c-Jun NH2-terminal kinase,
IKK-e, and inflammasome activation (21–26). The activa-
tion of these signaling pathways impairs insulin signaling
in adipocytes. As such, genetic and pharmacological in-
hibition of these pathways leads to attenuation of in-
flammatory signaling and improved insulin sensitivity.
Multiple proinflammatory cytokines have been impli-
cated in obesity-induced inflammation and contribute to
the development of insulin resistance (1,27). While it is
unlikely that the actions of any single cytokine could ac-
count for the complex and reciprocal interactions between
immune cells and adipocytes, IFN-g has emerged as
a uniquely important cytokine in this context. IFN-g
transduces signals through the JAK/STAT pathway (28),
particularly transcription factor STAT-1, and has been
demonstrated to attenuate insulin signaling and lipid
metabolism in adipocytes (29). Notably, mice lacking
IFN-g have reduced adipose tissue inflammation and im-
proved metabolic homeostasis (30), suggesting that IFN-g
signaling is a key player that sustains a proinflammatory
state in obesity. Despite a plethora of evidence supporting
the pathogenic role of chronic inflammation, whether
obesity activates adaptive pathways that counteract in-
flammation and the extent to which they contribute to
metabolic homeostasis remain largely unknown.
Otopetrin 1 (Otop1) is a member of the otopetrin
domain protein family that is highly conserved in species
ranging from nematodes to vertebrates (31,32). Otop1 is
predicted to contain 12 transmembrane domains and has
been demonstrated to localize to the plasma membrane
(33). Mice harboring tilted mutation (A151E, Otop1tlt)
have impaired otoconia development (34), likely as
a consequence of altered cellular calcium in vestibular
supporting cells (33,35). Importantly, Otop1 knockout
mice develop similar defects in otoconia formation (36),
suggesting that Otop1tlt mutant represents a bona fide
loss-of-function allele. Whether Otop1 is expressed in
peripheral tissues and regulates other physiological pro-
cesses remains unknown. In this study, we found that
Otop1 is induced in WAT during obesity and counteracts
obesity-associated adipose tissue inflammation. Otop1
defines a novel adaptive mechanism that maintains
metabolic homeostasis through attenuating chronic
inflammation.
RESEARCH DESIGN AND METHODS
Animals and Animal Care
All animal studies were performed following the guideline
established by the University Committee on Use and Care
of Animals at the University of Michigan. Mice were housed
in a specific pathogen-free facility at 77°F with a 12-h light,
12-h dark cycle and free access to food and water. For chow
diet feeding, male wild-type (WT) C57BL/6J mice and
Otop1tlt mice were fed with Teklad 5001 laboratory diet.
For high-fat diet (HFD) feeding, mice were fed with a diet
consisting of 60% of calories from fat (D12492, Research
Diets Inc.) starting at 10 to 12 weeks of age.
Adipocyte Isolation and Differentiation
Immortalization and differentiation of brown adipocytes
were performed as described (37). Briefly, SV40 large
T antigen-immortalized brown preadipocytes were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) with 10%
FBS. Differentiation was induced 2 days postconfluence (day
0) by adding a cocktail containing 0.5 mmol/L 3-isobutyl-1-
methylxanthine, 125 mmol/L indomethacin, and 1 mmol/L
dexamethasone to the maintenance media (DMEM
supplemented with 10% FBS, 20 nmol/L insulin, and
1 nmol/L T3). Two days after induction, cells were cul-
tured in the maintenance media alone. Total RNA was
isolated at different days for gene expression analysis.
3T3-L1 fibroblasts were cultured in DMEM with 10%
bovine growth serum until 2 days postconfluent. Dif-
ferentiation was induced by adding a cocktail containing
0.5 mmol/L 3-isobutyl-1-methylxanthine, 1 mmol/L
dexamethasone, and 1 mg/mL insulin to DMEM supple-
mented with 10% FBS. Three days after induction, cells
were cultured in DMEM containing 10% FBS plus 1 mg/mL
of insulin for 2 more days followed by maintenance in
DMEM supplemented with 10% FBS. TNF-a, IFN-g, and
lipopolysaccharide (LPS) treatments were carried out in
mature adipocytes cultured in the maintenance media.
Adipose Tissue Explant Culture
Epididymal WAT (eWAT) was dissected and transferred to
a petri dish with 20 mL DMEM, cut into pieces with
diameters less than 4 mm (;5–10 mg). Tissue pieces were
filtered through 200 mm nylon mesh, washed once with
103 volume PBS and then with 103 volume DMEM,
transferred into six-well plates with serum-free M199
media (1 nmol/L insulin, 1 nmol/L dexamethasone), and
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cultured for 2 h before IFN-g treatment at 10 ng/mL for 4
h. Following treatments, fat tissues were quickly dried on
paper towels and processed for RNA isolation and quan-
titative real-time PCR (qPCR) gene expression analysis.
Metabolic and Gene Expression Analyses
Plasma concentrations of free glycerol and triglycerides
(Sigma), b-hydroxybutyrate (Stanbio Laboratory), and
nonesterified fatty acid (Wako Diagnostics) were measured
using commercial assay kits. Liver triglyceride was extracted
and measured as previously described (38). Plasma in-
sulin was measured using an ELISA kit (CrystalChem).
Glucose and insulin tolerance tests were performed as
previously described (39). For insulin signaling studies,
mice were fed HFD for 8 weeks before receiving
a single dose of intravenous injection of saline or insulin
(1.5 units/kg). Tissues were rapidly dissected 10 min
after injection for immunoblotting analyses.
For gene expression analysis, total RNA from WAT
was extracted using a commercial kit from Invitrogen.
Total RNA from other tissues and cultured cells was
extracted using the TRIzol method. For qPCR analysis,
equal amount of RNA was reverse-transcribed using
Moloney murine leukemia virus reverse transcriptase
followed by qPCR reactions using SYBR Green (Life
Technologies). Relative abundance of mRNA was nor-
malized to ribosomal protein 36B4. Adipose tissue and
liver gene expression was analyzed using specific primers
(Supplementary Table 1). Statistical significance was de-
termined by Student t test.
Figure 1—Otop1 is induced in obese WAT in response to proinflammatory cytokine signaling. (A) qPCR analysis of Otop1 expression in
tissues from WT mice fed chow (n = 5) or HFD (n = 6) for 3 months (left) and from a separate group of WT (n = 4) and db/db mice (n = 4).
Data represent mean 6 SEM. *P < 0.01, obese vs. lean. (B) Correlation of eWAT Otop1 expression with body weight. Relative Otop1
mRNA levels were plotted against respective body weight. (C) qPCR analysis of SVF and mature adipocyte fractions isolated from eWAT
from mice fed chow (n = 3) or HFD (n = 3). Data represent mean6 SEM. *P< 0.01, obese vs. lean. (D) qPCR analysis of 3T3-L1 adipocytes
treated with indicated concentrations of TNF-a for 6 h. qPCR analysis of 3T3-L1 adipocytes treated with IFN-g (E ) or LPS (F ) for 6 h. Data
in D–F represent mean 6 SD from one representative study performed in triplicate wells. *P < 0.01, vs. saline. Adi, adipocyte.
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Immunoblotting Analyses
Tissues were homogenized in a lysis buffer containing
50 mmol/L Tris (pH 7.5), 150 mmol/L NaCl, 5 mmol/L
NaF, 25 mmol/L b-glycerolphosphate, 1 mmol/L sodium
orthovanadate, 10% glycerol, 1% tritonX-100, 1 mmol/L
dithiothreitol, and freshly added protease inhibitors. Im-
munoblotting experiments were performed using specific
antibodies and visualized on film using horseradish
peroxidase–conjugated secondary antibodies (Sigma and
Cell Signaling) and Western Chemiluminescent HRP
Substrate (Millipore). Phospho-STAT1 (Y701), phospho-
STAT3 (Y705), phospho-STAT5 (Y694), STAT1, STAT3,
STAT5, phospho-TBK1 (S172), TBK1, NFkB-p65,
phospho-NFkB-p105 (Ser933), NFkB-p105, phospho-
AKT (Ser473), phospho-AKT (T308), and AKT antibody
were purchased from Cell Signaling Technology. Anti-
bodies against PPAR-g (Santa Cruz Biotechnology), HA
(sc-66181), Flag (Sigma), and tubulin (Sigma) were used.
Affinity Purification of Otop1 Protein Complex
Total cell lysates were prepared from mature brown
adipocytes stably expressing murine stem cell virus-
vector or murine stem cell virus-Flag-HA-Otop1. Se-
quential steps of affinity purification was performed
using anti-HA (Roche) and anti-Flag (Sigma) affinity
matrix followed by eluting with 200 mg/mL HA and Flag
peptides, respectively. Eluted protein complex was ana-
lyzed by SDS-PAGE. Following colloidal blue staining,
individual bands were excised for protein identification
by mass spectrometry.
Figure 2—Otop1tlt mutant mice develop more severe HFD-induced insulin resistance. (A) Body weight of WT (open diamond; n = 8) and
Otop1tlt mice (filled circle; n = 8) during HFD feeding. (B) Plasma concentrations of b-hydroxybutyrate, nonesterified fatty acids, and
triglycerides after overnight fasting. (C) Plasma glucose and insulin levels under fed and fasted conditions. (D) Insulin tolerance test in WT
(n = 6) and Otop1tlt (n = 7) mice in HFD-fed mice. (E) Glucose tolerance test in WT (n = 8) and Otop1tlt mice (n = 8) 9 weeks after HFD
feeding. Data represent mean 6 SEM. *P < 0.05, Otop1tlt vs. WT. NEFA, nonesterified fatty acids.
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Fluorescence-Activated Cell Sorter Analysis
Adipose tissue fractionation, flow cytometry analysis,
and whole-mount immunofluorescence staining were
performed as previously described (15,16). Blood
leukocytes and stromal vascular cells were incubated
in Fc Block (rat anti-mouse CD16/32; eBioscience) for
10 min and then stained with CD45-e450, CD11b-APC-Cy7,
CD11c-PE-Cy7, CD301-APC, and F4/80-PE (eBioscience)
or appropriate isotype controls for 30 min. Labeled cells
were then washed twice with fluorescence-activated
cell sorter buffer followed by fixation in 1% para-
formaldehyde in PBS. Cells were analyzed on FACSCanto
II Flow Cytometer (BD Biosciences) using FlowJo soft-
ware (version 9.6; Treestar). For whole-mount immu-
nostaining, adipose tissue samples were fixed with 1%
paraformaldehyde and stained with anti-caveolin and
anti-Mac2 antibodies in PBS-T/BSA. Samples were im-
aged on an inverted confocal microscope using FluoView
software (Olympus).
Statistics
Data were analyzed using two-tailed Student t test for
independent groups. A P value of less than 0.05 was
considered statistically significant.
RESULTS
Otop1 Is Induced in Obese WAT in Response to
Proinflammatory Signaling
Adipose tissue inflammation is emerging as a pathogenic
link between obesity and metabolic disorders. The sus-
tained chronic inflammation is associated with a pheno-
typic switch of resident immune cells from anti-
inflammatory to proinflammatory subtypes in adipose
tissues (15,17). Whether obesity also activates adaptive
mechanisms to counteract inflammation caused by
chronic overnutrition remains largely unexplored. Otop1
mRNA expression is present in BAT but nearly un-
detectable in eWAT from lean mice. Interestingly, Otop1
mRNA level was markedly increased in eWAT following
Figure 3—Impaired insulin-stimulated AKT phosphorylation in Otop1tlt mouse tissues. Eight weeks after HFD feeding, tissues were
harvested from WT and Otop1tlt mice 10 min after a single intravenous injection of saline or insulin. Immunoblots of total tissue lysates
(left). Quantitation of phosphorylated AKT was performed following normalization to total AKT levels (right). *P < 0.05, Otop1tlt vs. WT.
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HFD-induced obesity (Fig. 1A). Compared with WT,
Otop1 mRNA expression was increased by approximately
80-fold in eWAT from leptin receptor deficient (db/db)
mice. Similar increase in Otop1 expression was also ob-
served in inguinal fat from obese mice (data not shown).
In contrast, Otop1 mRNA levels in BAT remained similar
between lean and obese mice (Fig. 1A). We did not detect
changes in Otop1 mRNA expression by HFD in other
tissues, including skeletal muscle and liver. To determine
whether Otop1 expression in eWAT correlates with the
severity of obesity, we fed a cohort of C57BL/6J male
mice with HFD for 10 weeks to induce obesity. Mice fed
HFD gained variable body weight and exhibited different
degrees of obesity and insulin resistance. Gene expres-
sion analysis in this cohort indicated that eWAT Otop1
expression was strikingly correlated with body weight of
individual mice (Fig. 1B). This increase in Otop1 expres-
sion in obese eWAT was due to its induction in mature
adipocytes, but not other cell types in the stromal vas-
cular fraction (SVF) (Fig. 1C). Expression of leptin was
included as markers for mature adipocytes.
Obesity-associated chronic inflammation is charac-
terized by augmented production of proinflammatory
cytokines in adipose tissues, such as TNF-a, IFN-g,
IL-1b, and IL-6 (1,20,40). To determine whether Otop1
induction is triggered by proinflammatory cytokines, we
treated differentiated 3T3-L1 adipocytes with TNF-a,
IFN-g, or LPS and examined gene expression using qPCR.
Compared with control treatments, mRNA expression of
Otop1 and IL-6, the latter being a known target gene of
TNF-a, was induced by TNF-a in a dose-dependent
manner (Fig. 1D). In contrast, while IFN-g and LPS in-
duced the expression of their respective target genes
(Ifih1 and Ccl5) in 3T3-L1 adipocytes, these treatments
had modest effects on Otop1 mRNA expression (Fig. 1E
and F). These results suggest that obesity-associated
Figure 4—Otop1tlt mutant mice develop more severe diet-induced hepatic steatosis. (A) H&E staining of liver sections in WT and Otop1tlt
mice fed chow or HFD for different periods of time (scale bar = 100 mm). (B) Stimulated Raman scattering imaging of liver sections. Arrows
indicate lipid droplets (scale bar = 25 mm). (C) Liver/body weight ratio and liver triglyceride content in WT (open; n = 8) and Otop1tlt (filled;
n = 8) mice after 3 months of HFD feeding. (D) qPCR analysis of hepatic gene expression in WT and Otop1tlt mice. Data in C and D
represent mean 6 SEM. *P < 0.05, Otop1tlt vs. WT. TG, triglyceride.
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induction of Otop1 in WAT is likely a direct consequence
of heightened adipose tissue inflammation.
Otop1 Mutant Mice Develop More Severe Diet-Induced
Metabolic Disorders
While the deleterious effects of innate immune activation
have been well established, whether obesity engages an
adaptive response to counteract inflammation in adipose
tissues has not been elucidated. We next sought to assess
the significance of Otop1 in adipose tissue homeostasis,
particularly in the context of obesity. WT and Otop1tlt
mutant mice gained similar body weight after 12 weeks of
HFD feeding (Fig. 2A). Plasma concentrations of non-
esterified fatty acids and b-hydroxybutyrate, but not tri-
glycerides, were lower in Otop1tlt mutant mice (Fig. 2B).
Despite a lack of difference in body weight gain, fasting
blood glucose and insulin levels were significantly elevated
in the mutant mice (Fig. 2C). While blood glucose levels
were similar under fed conditions, plasma insulin con-
centration was elevated in Otop1tlt mutant mice. Further,
insulin and glucose tolerance tests indicated that mutant
mice developed more severe insulin resistance (Fig. 2D
and E), suggesting that Otop1 is required for maintaining
insulin sensitivity in diet-induced obesity. In support of
this, basal levels of phosphor-AKT were also reduced in
adipose tissues and skeletal muscle. Importantly, insulin-
stimulated AKT phosphorylation was markedly blunted in
several tissues from HFD-fed Otop1tlt mutant mice, in-
cluding WAT, BAT, liver, and skeletal muscle (Fig. 3). We
conclude from these studies that obesity-induced expres-
sion of Otop1 in WAT may serve a beneficial role in
maintaining metabolic homeostasis in the state of chronic
overnutrition.
We performed hematoxylin-eosin (H&E) staining on liver
sections from mice fed standard chow or HFD for different
periods of time and found that Otop1tlt mice developed
Figure 5—Otop1 mutant mice have exacerbated adipose tissue inflammation following HFD feeding. (A) H&E staining of eWAT from WT
and Otop1tlt mice fed chow or HFD for different periods of time. Scale bar indicates 100 mm. (B) Confocal images of eWAT following
whole-mount immunofluorescence staining using caveolin (green) and Mac2 (red) antibodies (scale bar = 50 mm). (C) H&E staining of BAT
from WT and Otop1tlt mice fed with HFD for 3 months. (D) Flow cytometry analyses of adipose tissue macrophages in SVF of eWAT from
HFD-fed WT (n = 8) and Otop1tlt (n = 7) mice. (E) Flow cytometry analyses of adipose tissue macrophage in iWAT from mice in D. Data in D
and E represent mean 6 SEM. *P < 0.05, #P < 0.1, Otop1tlt vs. WT. ATM, adipose tissue macrophage.
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more severe hepatic steatosis after 2 months on HFD (Fig.
4A). These histological findings were confirmed by stimu-
lated Raman scattering microscopy, a label-free imaging
method that detects cellular lipids by measuring molecular
vibrations of fatty-acyl chains (41,42). As shown in Fig. 4B,
pericentral hepatocytes from Otop1tlt mutant mice had
larger lipid droplets compared with control following 2 and 3
months of HFD feeding. Measurements of liver triglyceride
content after 3 months of HFD feeding revealed that
Otop1tlt mice had ;58% higher hepatic triglyceride content
than WT controls (Fig. 4C). In addition, liver/body weight
ratio was significantly higher in the mutant mice. Gene ex-
pression analysis indicated that mRNA levels of Fsp27 and
Plin4, two lipid droplet proteins, were significantly elevated
in Otop1tlt mutant livers (Fig. 4D). The expression of per-
oxisomal enoyl-CoA hydratase (Ehhadh) and HMG-CoA
synthase 2 (Hmgcs2), genes involved lipid metabolism, but
not fibroblast growth factor 21 (Fgf21), was lower in mutant
livers. Because Otop1 expression was nearly undetectable in
the liver in lean and obese mice, the exacerbation of hepatic
steatosis in mutant mice is most likely secondary to altered
adipose tissue metabolism and function.
Otop1 Mutant Mice Exhibit More Severe Adipose
Tissue Inflammation Following HFD Feeding
As described above, Otop1 expression was elevated in
mouse WAT in obesity and was induced in response to
TNF-a treatments in cultured adipocytes (Fig. 1). To our
surprise, Otop1 mutant mice showed exacerbated diet-
induced insulin resistance and hepatic steatosis. These
findings suggest a plausible mechanism where Otop1
contributes to metabolic homeostasis by counteracting
obesity-induced adipose tissue inflammation. In support
of this, we found that Otop1tlt mutant mice developed
progressively more severe adipose tissue inflammation
and increased macrophage infiltration as revealed by
H&E and whole-mount immunofluorescence staining
(Fig. 5A and B). Compared with WT, the presence of
crown-like structures, characteristic of inflamed adipose
tissues in obesity, was more pronounced in Otop1tlt
mutant eWAT. In contrast, the histological appearance of
BATs was similar between the two groups (Fig. 5C). We
next analyzed the characteristics of adipose tissue mac-
rophages using flow cytometry with specific cell surface
markers. Compared with WT, Otop1tlt mutant eWAT had
higher proportion of CD3012CD11c+ classically polarized
(M1) macrophages, whereas alternatively activated (M2)
macrophages (CD301+CD11c2) were significantly lower
(Fig. 5D). Consequently, the M1/M2 ratio was signifi-
cantly increased in Otop1tlt mutant eWAT. Similar
changes in M1/M2 macrophages were also observed in
inguinal WAT (iWAT) from Otop1tlt mice (Fig. 5E), though
the differences only achieved borderline significance.
Figure 6—Otop1 negatively regulates WAT inflammation and IFN-g response. (A) Immunoblots of inflammation markers in total eWAT
lysates from HFD-fed mice. Fold change in Otop1tlt samples was quantitated following normalization to tubulin. *P< 0.05, Otop1tlt vs. WT.
(B) qPCR analysis of eWAT and iWAT gene expression in HFD-fed WT (n = 8) and Otop1tlt (n = 8) mice for 3 months. Data represent
mean 6 SEM. *P < 0.05, Otop1tlt vs. WT. (C) qPCR analysis of epididymal fat explants from WT and Otop1tlt mutant mice without or with
IFN-g stimulation. Data represent mean 6 SD from triplicate wells. *P < 0.05, Otop1tlt vs. WT.
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We next performed immunoblotting and qPCR anal-
yses to examine molecular changes in adipose tissues
from HFD-fed control and Otop1 mutant mice. Immu-
noblotting studies revealed that protein levels of IKK-e,
a target of NFkB recently implicated in obesity-induced
adipose tissue inflammation (23,43), were increased in
Otop1 mutant eWAT (Fig. 6A). Consistently, NFkB-p105,
phospho-NFkB-p105, and NFkB-p65 protein levels were
elevated in Otop1tlt mutant eWAT. Total TBK1 and
phospho-TBK1 protein levels were also higher in Otop1tlt
mutant eWAT. mRNA expression of many metabolic
genes was similar between two groups, including PPAR-g
and Srebp1c, key regulators of adipocyte gene expression,
hormone-sensitive lipase (Hsl), adipose triglyceride lipase
(Atgl), and Ehhadh (Fig. 6B). Consistent with changes in
macrophage subtypes, we found that mRNA expression
of macrophage marker F4/80 was elevated, whereas the
expression of arginase 1 (Arg1), a marker for M2 mac-
rophages, was significantly lower in mutant eWAT. The
expression levels of Mac2 and Cd68 were also elevated
in Otop1 mutant iWAT. In contrast, the expression
of TNF-a and many IFN-g target genes, including
29-59 oligoadenylate synthetase-like-1 (Oasl1), Oasl2,
IFN-induced protein 44 (Ifi44), and IFN-induced trans-
membrane protein 3 (Ifitm3), was significantly higher in
Otop1tlt eWAT than control. Similar induction of mac-
rophage markers and IFN-g target genes was observed in
Otop1tlt mutant mouse iWAT (Fig. 6B). Because IFN-g
expression remained largely unaltered, the induction of
its target genes in mutant WAT is likely due to aug-
mented IFN-g signaling in Otop1tlt mutant adipocytes.
To directly test this, we treated epididymal fat explants
from HFD-fed WT and Otop1tlt mutant mice with IFN-g
and examined target gene responses. The induction of
several IFN-g target genes, including Oasl2, Ifi44, Ifih1,
and IFN regulatory factor-1 (Irf1), was significantly higher
in Otop1tltmutant fat explants than control in response to
IFN-g stimulation (Fig. 6C). Together, these results sug-
gest that Otop1 induction in obese WAT is likely an
adaptive homeostatic response that exerts a protective role
by counteracting obesity-induced adipose inflammation.
Otop1 Interacts With STAT1 and Attenuates IFN-g
Signaling in Adipocytes
To explore the molecular mechanisms by which Otop1
modulates IFN-g signaling, we ectopically expressed
Figure 7—Otop1 physically interacts with STAT1 and regulates IFN-g response in adipocytes. Immunoblots of total cell lysates and
immunoprecipitated (IP) proteins (anti-HA) from differentiated 3T3-L1 adipocytes (A) or brown adipocytes (B) stably expressing vector or
Flag-HA-tagged Otop1 and treated with vehicle or IFN-g. (C ) Immunoblots of total cell lysates from brown adipocytes stably expressing
vector or Otop1 treated with saline (-) or IFN-g (+) for indicated time. Vec, vector; FHO, Flag-HA-tagged Otop1.
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Flag-HA-tagged Otop1 in 3T3-L1 and immortalized
brown preadipocytes and performed immunoaffinity
purification of the Otop1 protein complexes. Mass
spectrometry and immunoblotting analyses indicated
that Otop1 physically interacted with STAT1 (Fig. 7A
and B), a transcription factor that plays a critical role in
IFN-g signaling (28). The interaction between Otop1
and STAT1 appears to be independent of STAT1 phos-
phorylation (Fig. 7B). To determine whether the exacer-
bation of adipose tissue inflammation in Otop1 mutant
mice results from cell-autonomous effects of Otop1 on
inflammatory signaling, we first examined the response
of WT and Otop1 mutant adipocytes to IFN-g treat-
ments. Because brown adipocytes express endogenous
Otop1, we immortalized brown preadipocytes from
WT and Otop1 mutant neonates and performed studies
following adipocyte differentiation. As expected, IFN-g
treatments strongly induced tyrosine phosphorylation
of STAT1, STAT3, and STAT5 but only had modest
effects on the NFkB and IKK-e/TBK1 pathways (Fig. 7C).
Total and phosphorylated STAT3 and STAT5 proteins
were comparable between WT and Otop1 mutant adi-
pocytes. In contrast, total STAT1 protein levels were el-
evated in mutant adipocytes, resulting in more robust
tyrosine phosphorylation in response to IFN-g treatments.
We performed microarray studies to identify down-
stream pathways that were affected by Otop1 mutation.
Consistent with the eWAT gene expression profile, the
expression of a large number of IFN-g target genes, in-
cluding Oasl1, Oasl2, Ifi44, Ifitm3, and Ifih1, was signifi-
cantly elevated in Otop1 mutant adipocytes compared
with control (Fig. 8A). In response to IFN-g treatments,
mRNA expression of these target genes was induced to
higher levels in Otop1 mutant adipocytes compared with
WT control (Fig. 8B). These results strongly suggest that
Otop1 attenuates IFN-g signaling in adipocytes through
its physical interaction with STAT1 (Fig. 8C).
We further assessed whether ectopic overexpression of
Otop1 attenuates the IFN-g/STAT1 signaling pathway in
adipocytes. We treated differentiated brown adipocytes
expressing vector or Otop1 with IFN-g and examined
STAT1 protein levels and phosphorylation. Compared
with vector, Otop1 overexpression significantly decreased
total STAT1 protein levels and phosphorylated STAT1
following IFN-g stimulation (Fig. 9A). In contrast, protein
levels of STAT3, NFkB, and IKK-e/TBK1 remained largely
unaltered by Otop1. Basal STAT5 phosphorylation is
slightly lower in adipocytes overexpressing Otop1, yet the
differences disappeared after IFN-g treatment. Consistent
with decreased STAT1 levels, basal expression of IFN-g
targets such as Ifi44, Oasl1, Oasl2, and Ifih1 was reduced
by retroviral-mediated overexpression of Otop1 (Fig. 9B).
Further, the induction of these genes in response to IFN-g
was also significantly dampened in Otop1-overexpressing
adipocytes. Taken together, we conclude that Otop1 neg-
atively regulates IFN-g signaling in adipocytes and may
Figure 8—IFN-g signaling is augmented in Otop1tlt mutant adipocytes. (A) Clustering analysis of IFN-g target genes in differentiated
WT and Otop1tlt brown adipocytes. (B) qPCR analysis of gene expression in differentiated adipocytes treated with saline (-) or 10 ng/mL
IFN-g (+) for 4 h. Data represent mean 6 SD from triplicate wells. *P < 0.05, Otop1tlt vs. WT. (C) Model depicting the role of Otop1 in
counteracting obesity-associated inflammation in adipocytes. Otop1 expression is induced by TNF-a in white fat during obesity. The
induction of Otop1 serves to attenuate proinflammatory cytokine signaling in adipocytes and maintain adipose tissue function and
systemic metabolic homeostasis.
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serve to counteract chronic proinflammatory immune re-
sponse in obese adipose tissues.
DISCUSSION
The pathogenic role of chronic inflammation in the de-
velopment of obesity-associated metabolic disease has
been well established. Attenuation of inflammatory sig-
naling generally resulted in improved metabolic profiles
in rodent models of obesity. While counterinflammation
has been proposed as a key aspect of homeostatic regu-
lation (44), the molecular components of this negative
feedback arm remain elusive. In this study, we identified
Otop1 as an obesity-induced target of cytokine signaling
in WAT. Otop1 mutant mice develop more severe diet-
induced insulin resistance and hepatic steatosis that are
accompanied by augmented adipose tissue inflammation.
Otop1 interacts with Stat1 and attenuates IFN-g sig-
naling in adipocytes in a cell-autonomous manner.
Together, these studies illustrate a novel pathway that
counteracts obesity-associated chronic inflammation and
preserves metabolic homeostasis in obesity (Fig. 8C).
A remarkable aspect of Otop1 expression in WAT is
that it is highly induced during obesity. Thus mRNA
levels of Otop1 in WAT correlate tightly with the degree
of HFD-induced obesity. Elevated expression of Otop1
was also observed in white fat depots from db/db mice.
While it is possible that the induction of Otop1 expres-
sion in obese adipose tissues may result from changes
in cell populations in WAT, gene expression analyses in
fractionated adipocytes and stromal vascular cells
indicated that Otop1 induction occurred exclusively in
adipocytes. Otop1 mRNA was nearly undetectable in the
SVF. The stimuli that drive obesity-associated induction
of Otop1 in adipocytes may be multifaceted in nature. In
cultured 3T3-L1 adipocytes, the proinflammatory cyto-
kine TNF-a, but not IFN-g and LPS, strongly induced
Otop1 expression in a dose-dependent manner, sug-
gesting that Otop1 is likely a target downstream of
a subset of proinflammatory signals.
Otop1 mutant mice developed diet-induced obesity at
similar pace compared with controls, suggesting that
Otop1 does not play a major role in the regulation of
whole body energy balance. A surprise here is that the
mutant mice developed more severe insulin resistance
and hepatic steatosis. Because Otop1 expression was
not detected in the liver in lean and obese mice, the
Figure 9—Otop1 attenuates IFN-g signaling in adipocytes. (A) Immunoblots of total cell lysates from brown adipocytes stably expressing
vector or Otop1 treated with saline or IFN-g for 15 or 30 min. (B) qPCR analysis of gene expression in differentiated brown adipocytes
stably expressing vector or Otop1 treated with saline (-) or 10 ng/mL IFN-g (+) for 4 h. Data represent mean6 SD from triplicate wells. *P<
0.05, Otop1 vs. vector. Vec, vector.
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exacerbation of liver fat accumulation in HFD-fed Otop1
mutant mice was most likely secondary to the metabolic
perturbations that occurred in mutant adipose tissues. In
support of this, we found that the formation of crown-
like structures, which are indicative of adipocyte death
and inflammatory response, was accelerated in Otop1
mutant adipose tissue. The increase in crown-like struc-
tures was accompanied by a shift in macrophage polari-
zation toward a proinflammatory subtype. Accordingly,
mRNA and protein markers of inflammatory signaling
were also elevated in Otop1 mutant eWAT following
HFD feeding. These observations are consistent with
a critical role for Otop1 in attenuating obesity-associated
inflammation. This mechanism is apparently distinct
from the counterinflammatory actions of noncanonical
IKKs, i.e., IKK-e and TBK1, which are induced in obesity
to sustain chronic inflammation in adipose tissue
(23,43). Recent studies have also implicated GPR120 as
a sensor for anti-inflammatory fatty acids with insulin-
sensitizing effects (45). However, GPR120 appears to act
primarily in macrophages. As such, concerted activation
of counterinflammation in both adipocytes and immune
cells is required for maintaining normal adipose tissue
function and metabolic homeostasis.
The mechanisms by which Otop1 exerts its anti-
inflammatory effects appear to be mediated, at least in
part, by attenuating IFN-g signaling in adipocytes. IFN-g
is primarily produced by natural killer and T cells and
plays an important role in M1 macrophage activation
(46). IFN-g also directly activates its receptors on adi-
pocytes and elicits its effects on cytokine expression and
metabolism (29,47). Interestingly, IFN-g deficient mice
have an improved metabolic profile following HFD
feeding (30,48), suggesting that excess IFN-g signaling
may have deleterious effects on adipose tissue function
and systemic metabolism. The expression of a number of
IFN-g target genes was elevated in Otop1 mutant eWAT.
Importantly, the inhibitory effects of Otop1 on IFN-g
target gene expression appears to be cell autonomous, as
Otop1 mutant adipocytes have elevated expression of
these genes at baseline. In response to IFN-g treatments,
the induction of these genes was further augmented. In
contrast, overexpression of Otop1 in adipocytes signif-
icantly blunted IFN-g-induced gene expression. These
gain- and loss-of-function studies suggest that exacerbated
adipose tissue inflammation in Otop1 mutant mice is
likely due to augmented proinflammatory cytokine sig-
naling in adipocytes. At the molecular level, Otop1 phys-
ically interacts with STAT1, a downstream transcription
factor essential for IFN-g signaling, and selectively reduces
STAT1 protein expression in adipocytes. The biochemical
mechanisms underlying the downregulation of STAT1 by
Otop1 remain currently unknown.
Previous studies have established the framework for
the involvements of chronic inflammation in the patho-
genesis of obesity-related adipose tissue dysfunction and
metabolic disease. However, surprisingly little is known
about potential activation of anti-inflammatory path-
ways that may counterbalance excess inflammation in
the state of overnutrition. Disruption of the proin-
flammatory signaling cascades via genetic or pharmaco-
logical means has been proven effective in mitigating
metabolic disease. As such, it is only logical to speculate
that a putative component of the anti-inflammatory arm
is itself a target of inflammatory signaling and that the
deficiency of this counterregulatory arm may worsen
obesity-induced metabolic disorders. Thus Otop1 is likely
a component of a novel counterinflammatory signaling
pathway that maintains adipose immune homeostasis in
obesity. Activation of this adaptive pathway may provide
metabolic benefits in obesity.
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